To commence operation by 2027…with max. 400K liters of plasma production capacity per annum The first step towards localization of Indonesia’s critical medical product YONGIN, South Korea, Dec. 5, 2023 /PRNewswire/ — GC Biopharma, a South Korean biopharmaceutical company, announced on…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.